Bora Pharmaceuticals to Acquire GSK's Facility in Canada
Shots:
- Bora acquires GSK’s facility located in Mississauga- Ontario (Canada) which produces ~50 products and employs ~400 skilled manufacturing staff. The transaction is expected to be completed in H2’20
- As per the transaction- GSK’s staff will join the Bora which will continue to manufacture the existing GSK’s product line for a minimum of five years. The facility will move to a new location within a timeframe- following the closure of the transaction
- The acquisition will boost Bora’ technical capabilities & enables it to locally support its core markets of North America and Asia
Click here to read full press release/ article
Ref: Bora Pharmaceutical | Image: GSK
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com